Close
❮
❯
Enverus Home
docFinder
M&A
Learn More
Videos
About Us
Contact Us
Register
Log In
Username (email)
Password
Remember Me
Forgot Password?
or
Sign Up Now!
New Search*
Back to Results
Note: Only one slide is currently available because you are not currently logged in.
Full Document
Key Slides
ENI S.p.A.
|
Q1 2024 Earnings Presentation
| Claudio Descalzi | Page 3 of 11 |
May 07, 2024
Save
Email
Print
View in Results
toolButton
prevButton
nextButton
prevKeyButton
nextKeyButton
prevKeyButton
nextKeyButton
byDateAscButton
byDateDescButton
byCompanyNameAscButton
byCompanyNameDescButton
hidden
hidden
Document:
"Q1 2024 Earnings Presentation"
View Full Document
×
Search Selection
Search by Text
Search
Search by Slide
Search
Cross reference your docFinder results against PLS' extensive news archives.
For demo or training contact Melwyn Oommen,
melwyn.oommen@drillinginfo.com
Slides may show historical information no longer relevant. All slides to be viewed in context of the entire presentation and time. See
Legal Disclaimer
.
Next 200
First
Previous
Zoom
Next
Last
2024 2027 2023 2027 2030 Grow new platforms Integration of chemistry, environment & agriculture Integrated chain to market equity gas Asset back trading Leading Position in EU Distinctive Cashflow growth from a complementary mix of traditional and emerging businesses OUR EMERGING VALUE CHAIN OF THE FUTURE A TRANSITION-ORIENTED PORTFOLIO OFFERING GROWTH AND RETURNS 3 Medium-term ROACE outlook 10-15% ~10% 15+% ~10% 10-15% >17 Sector leading growth 2023 2027 2030 Underlying Reported 1.8 1.9 1.66 2023 2027 2030 14 >18 2023 2027 2030 3 >8 2023 2027 2030 >3 2023 2027 2030 Post 2030 >15 ~40 Pre 2030 >15 >5 12.6 >17 Medium and longer-term growth Exploration driven growth Time to market Accretive barrels Lower emissions Renewables growth Financial delivery Integrating customers Strong growth in the current decade Biorefining growth SAF optionality Integrating agri-feedstock Technology ownership Leading position In Europe Technical and commercial skills and know- how UPSTREAM GGP PLENITUDE ENILIVE CCUS BIOCHEMISTRY FINANCIALS 6% 14% 2 All figures at plan scenario, ex one-off. 1 Share of Versalis sales Production Mboed LNG Contracted MTPA Installed Capacity GW Bioref. Capacity MTPA CO 2 T&S GROSS CAPACITY MTPA Biochem. sales 1 CFFO 2 € bln 1.65 SAF Optionality